<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE343nnn/GSE343056/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE343056</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Whole-brain transcriptomic profiling of control, diabetic neuropathic pain, and baclofen-treated mice</name><description>This study investigated central transcriptional alterations associated with diabetic neuropathic pain and baclofen treatment. Whole-brain RNA sequencing was performed in control mice, untreated diabetic neuropathic pain mice, and baclofen-treated diabetic neuropathic pain mice. The dataset was used to assess GABAergic and inhibitory synaptic signaling, neuroinflammation, glial activation, and treatment-associated transcriptional modulation.</description><dates><publication>2026/08/13</publication></dates><accession>GSE343056</accession><cross_references><GSM>GSM9945369</GSM><GSM>GSM9945376</GSM><GSM>GSM9945368</GSM><GSM>GSM9945373</GSM><GSM>GSM9945372</GSM><GSM>GSM9945375</GSM><GSM>GSM9945374</GSM><GSM>GSM9945371</GSM><GSM>GSM9945370</GSM><GPL>24247</GPL><GSE>343056</GSE><taxon>Mus musculus</taxon><PMID>[42694153]</PMID></cross_references></HashMap>